COO Quote, Financials, Valuation and Earnings

Innovative Eyewear, Inc. has a net margin of 9.27% compared to The Cooper Cos., Inc.'s net margin of -274.85%. The Cooper Cos., Inc.'s return on equity of 5% beat Innovative Eyewear, Inc.'s return on equity of -80%.

The Cooper Cos., Inc. has a consensus price target of $83.00, signalling upside risk potential of 9.24%. On the other hand Innovative Eyewear, Inc. has an analysts' consensus of $3.00 which suggests that it could grow by 114.29%. Given that Innovative Eyewear, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Innovative Eyewear, Inc. is more attractive than The Cooper Cos., Inc..

The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison Innovative Eyewear, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Innovative Eyewear, Inc. pays out -- of its earnings as a dividend.

The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than Innovative Eyewear, Inc. quarterly revenues of $668.1K. The Cooper Cos., Inc.'s net income of $98.3M is higher than Innovative Eyewear, Inc.'s net income of -$1.8M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 37.41x while Innovative Eyewear, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.77x versus 1.90x for Innovative Eyewear, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

NexGel, Inc. has a net margin of 9.27% compared to The Cooper Cos., Inc.'s net margin of -22.05%. The Cooper Cos., Inc.'s return on equity of 5% beat NexGel, Inc.'s return on equity of -51.15%.

The Cooper Cos., Inc. has a consensus price target of $83.00, signalling upside risk potential of 9.24%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 275%. Given that NexGel, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe NexGel, Inc. is more attractive than The Cooper Cos., Inc..

The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.

The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than NexGel, Inc. quarterly revenues of $2.9M. The Cooper Cos., Inc.'s net income of $98.3M is higher than NexGel, Inc.'s net income of -$647K. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 37.41x while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.77x versus 1.05x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of 9.27% compared to The Cooper Cos., Inc.'s net margin of 7.29%. The Cooper Cos., Inc.'s return on equity of 5% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

The Cooper Cos., Inc. has a consensus price target of $83.00, signalling upside risk potential of 9.24%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 3.89%. Given that The Cooper Cos., Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe The Cooper Cos., Inc. is more attractive than Phibro Animal Health Corp..

The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.12 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than Phibro Animal Health Corp. quarterly revenues of $363.9M. The Cooper Cos., Inc.'s net income of $98.3M is higher than Phibro Animal Health Corp.'s net income of $26.5M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 37.41x while Phibro Animal Health Corp.'s PE ratio is 24.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.77x versus 1.21x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

STAAR Surgical Co. has a net margin of 9.27% compared to The Cooper Cos., Inc.'s net margin of 9.38%. The Cooper Cos., Inc.'s return on equity of 5% beat STAAR Surgical Co.'s return on equity of -25.83%.

The Cooper Cos., Inc. has a consensus price target of $83.00, signalling upside risk potential of 9.24%. On the other hand STAAR Surgical Co. has an analysts' consensus of $25.88 which suggests that it could fall by -1.88%. Given that The Cooper Cos., Inc. has higher upside potential than STAAR Surgical Co., analysts believe The Cooper Cos., Inc. is more attractive than STAAR Surgical Co..

The Cooper Cos., Inc. has a beta of 1.048, which suggesting that the stock is 4.779% more volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.806%.

The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.

The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than STAAR Surgical Co. quarterly revenues of $94.7M. The Cooper Cos., Inc.'s net income of $98.3M is higher than STAAR Surgical Co.'s net income of $8.9M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 37.41x while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.77x versus 5.68x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.